We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.71B
AUM Growth
-$44.3M
Cap. Flow
-$66.1M
Cap. Flow %
-2.44%
Top 10 Hldgs %
17.98%
Holding
299
New
64
Increased
62
Reduced
142
Closed
18

Top Sells

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$22.7M
2
TREX icon
Trex
TREX
+$17.5M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$15.4M
4
TTEK icon
Tetra Tech
TTEK
+$15.3M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$15.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 17.94%
3 Consumer Discretionary 17%
4 Industrials 15.63%
5 Financials 14.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIL
26
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$33.2M 1.23%
686,848
+61,237
+10% +$3M
MMSI icon
27
Merit Medical Systems
MMSI
$4.41B
$31.5M 1.16%
506,351
+56,564
+13% +$3.79M
KRTX
28
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$30.2M 1.12%
230,872
+18,850
+9% +$2.44M
NEO icon
29
NeoGenomics
NEO
$1.9B
$30.2M 1.11%
885,436
-18,862
-2% -$739K
SMCI icon
30
Super Micro Computer
SMCI
$15.6B
$30.1M 1.11%
6,845,290
+1,766,750
+35% +$7.16M
JACK icon
31
Jack in the Box
JACK
$286M
$30M 1.11%
342,599
-6,576
-2% -$611K
PLNT icon
32
Planet Fitness
PLNT
$4.14B
$29.2M 1.08%
321,878
-4,620
-1% -$394K
PLMR icon
33
Palomar
PLMR
$3.59B
$28.7M 1.06%
443,388
+34,615
+8% +$2.69M
EYE icon
34
National Vision
EYE
$1.66B
$28.6M 1.06%
595,831
-12,190
-2% -$653K
VIAV icon
35
Viavi Solutions
VIAV
$9.41B
$28.6M 1.05%
1,621,739
-31,110
-2% -$493K
ATRC icon
36
AtriCure
ATRC
$1.77B
$27.5M 1.02%
395,563
-8,426
-2% -$612K
REPL icon
37
Replimune Group
REPL
$859M
$26.8M 0.99%
989,958
+68,183
+7% +$2.04M
TNET icon
38
TriNet
TNET
$2.74B
$26.8M 0.99%
281,354
-122,636
-30% -$12.2M
VC icon
39
Visteon
VC
$2.8B
$26.5M 0.98%
238,395
+32,111
+16% +$3.57M
ARVN icon
40
Arvinas
ARVN
$517M
$26.1M 0.96%
318,175
+33,634
+12% +$2.74M
YETI icon
41
Yeti Holdings
YETI
$3.87B
$25.9M 0.95%
312,287
-9,543
-3% -$876K
HLI icon
42
Houlihan Lokey
HLI
$9.67B
$25.6M 0.94%
246,862
-4,861
-2% -$519K
LSCC icon
43
Lattice Semiconductor
LSCC
$17.2B
$25.1M 0.92%
325,169
-7,428
-2% -$551K
RAMP icon
44
LiveRamp
RAMP
$2.3B
$24.2M 0.89%
505,408
-10,351
-2% -$521K
SI
45
DELISTED
Silvergate Capital Corporation
SI
$23.7M 0.87%
159,638
-28
-0% -$4.79K
TFIN icon
46
Triumph Financial Inc
TFIN
$1.92B
$23.2M 0.86%
194,586
+26,097
+15% +$3.13M
OCFC icon
47
OceanFirst Financial
OCFC
$1.73B
$22.9M 0.84%
1,029,492
-18,626
-2% -$406K
MNKD icon
48
MannKind Corp
MNKD
$1.25B
$22.8M 0.84%
5,217,037
+987,748
+23% +$4.57M
FIVE icon
49
Five Below
FIVE
$11.2B
$22.7M 0.84%
109,860
-6,976
-6% -$1.37M
KTOS icon
50
Kratos Defense & Security Solutions
KTOS
$8.63B
$21.9M 0.81%
1,129,182
-16,229
-1% -$343K

Similar funds

Emerald Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Emerald Advisers held 299 positions worth $2.71B, down 1.6% from $2.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q4 2021 filing shows 64 new, 62 increased, 142 reduced and 18 closed positions. Its largest new stake was Herc Holdings: 116,724 shares worth $18.3M. The largest sale was Chegg, an estimated $22.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2021 buy was Herc Holdings: 116,724 shares worth $18.3M.
  • Emerald Advisers added most to Customers Bancorp in Q4 2021, an estimated $17.9M increase.
  • Emerald Advisers's biggest Q4 2021 reduction was Chegg, cutting an estimated $22.7M.
  • Emerald Advisers fully exited Oric Pharmaceuticals in Q4 2021, selling an estimated $15.2M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.71B portfolio in Q4 2021.
  • Emerald Advisers opened 64 new positions and closed 18 in Q4 2021.
  • Emerald Advisers's portfolio value fell 1.6% quarter-over-quarter to $2.71B.

Based on Emerald Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.